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Abstract
The distribution and appearance of nuclei are essential markers for
the diagnosis and study of cancer. Despite the importance of nuclear
morphology, there is a lack of large scale, accurate, publicly accessible
nucleus segmentation data. To address this, we developed an analysis
pipeline that segments nuclei in whole slide tissue images from multiple
cancer types with a quality control process. We have generated nucleus
segmentation results in 5,060 Whole Slide Tissue images from 10 cancer
types in The Cancer Genome Atlas. One key component of our work is
that we carried out a multi-level quality control process (WSI-level and
image patch-level), to evaluate the quality of our segmentation results.
The image patch-level quality control used manual segmentation ground
truth data from 1,356 sampled image patches. The datasets we publish in
this work consist of roughly 5 billion quality controlled nuclei from more
than 5,060 TCGA WSIs from 10 different TCGA cancer types and 1,356
manually segmented TCGA image patches from the same 10 cancer types
plus additional 4 cancer types1.
Background & Summary
Digital pathology images are obtained via a series of processes: tissue slicing,
staining, image capturing and digitization. The resolution of these images is
usually at multi-gigapixel level. A single tissue slide typically contains around
a million nuclei. The appearance, shape, texture, and morphological features
of nuclei depend on the tissue type excised from an organ, cancer type, cell
1Data available at https://doi.org/10.7937/tcia.2019.4a4dkp9u
ar
X
iv
:2
00
2.
07
91
3v
1 
 [e
es
s.I
V]
  1
8 F
eb
 20
20
type, and many other factors. The comprehensive detection, segmentation,
and classification of nuclei are core analysis steps in many histopathology image
analysis tasks [16, 7, 38, 9, 31, 4, 39, 36, 6, 41, 40, 3, 23, 26, 20]. Segmentation of
nuclei is the first step in extracting interpretable features that provide valuable
diagnostic and prognostic cancer indicators [11, 12, 28, 15, 1], and thus is a
crucial step for precision medicine [13, 8]. The Cancer Genome Atlas (TCGA)
program was a decade long, large scale National Cancer Institute led research
effort that molecularly characterized over 20,000 primary cancer and matched
control samples spanning 33 cancer types. Diagnostic whole slide images were
captured for a large fraction of TCGA patients. Deidentified whole slide images,
linked to molecular and clinical information are frequently accessed and analyzed
publicly available information. TCGA whole slide Pathology images have been
employed in many Cancer research efforts as well as in many digital Pathology
methodology studies; Cooper et al. [10], for instance, describes examples of how
TCGA whole slide images were used in integrative TCGA studies.
Current efforts to generate publicly accessible nuclear segmentation datasets
in Hematoxylin and Eosin (H&E) stained whole slide images have been at much
smaller scales than our work. Kumar et al. [23] collected a dataset of nu-
cleus segmentation in seven cancer disease sites. This dataset is used as the
MICCAI 2018 MoNuSeg challenge [24] in which the training set contains 30
image patches containing around 22,000 nuclear boundary annotations. The
MICCAI 2015 to MICCAI 2018 Segmentation of Nuclei challenge [25] train-
ing sets contain around 6,000 nuclear boundary annotations. Other datasets
[22, 37, 27, 21, 14] have similar or smaller numbers of segmented nuclei. For
these existing datasets, training patches are usually stain-balanced, well digi-
tized, and do not contain rare textures. However, in real world applications,
the appearance of nuclei can be affected by a number of staining and imaging
conditions: extremely high cellularity and nuclear pleomorphism, slightly out-
of-focus, folding tissue, imbalanced H&E staining, etc. Additionally, significant
segmentation ground truth data only exists for fewer than ten cancer types.
Existing experiments [19] showed that Convolutional Neural Networks (CNNs)
generalize sub-optimally in unseen cancer types (cancer types that do not have
training data). Therefore, training segmentation CNNs on existing datasets
naively yields poor segmentation results in WSIs [19].
We aimed to accurately segment nuclei in WSIs of multiple cancer types.
For this purpose, we leveraged a state-of-the-art nucleus segmentation Convo-
lutional Neural Network (CNN) that our group recently reported [19]. Our
approach has two advantages: (1). It generalizes well in cancer types that do
not have training data: it improves the robustness of the segmentation network
by synthesizing training data of every cancer type (2) The method is compu-
tationally efficient - this was critical given our goal of computing segmentation
results for over 5,000 WSIs. Given our ability to produce large scale synthetic
training data, a small U-net CNN [30] was able to generate accurate instance-
level segmentation results in 3 GPU hours per WSI. Computationally expensive
networks such as the Mask R-CNN [17] would achieve similar or worse across-
cancer type generalization performance but in over 30 GPU hours per WSI. By
combining three real training datasets [23, 35, 25] and a large scale synthetic
dataset of 500,000 image patches, we train a U-net that has two output heads:
one for nuclear center detection and one for nuclear material segmentation. We
finally applied the watershed method [5, 3] on detected centers and segmentation
results, to output instance-level segmentation.
No existing automatic segmentation models give perfect results. Visually
assessing segmentation results over 5,000 WSIs would take more than 200 human
hours (more than 2.5 minutes per WSI) which is very time consuming. Instead,
we apply the following methods for quality control and data validation:
Patch-level quantitative evaluation Wemanually segmented nuclei in 1,356
patches and leveraged this to quantitatively evaluate our 5,000+ WSI seg-
mentation dataset. In particular, we measured the segmentation overlap
using Dice scores, and the instance-level segmentation/detection quality
using Instance-Dice scores and the nuclei count correlation scores.
Random segmentation region checking and WSI-level quality control
(1) We sampled 15 patches per WSI, and visually assessed and manually
marked patches with what we considered to be adequate segmentation re-
sults (both precision and recall are at least 75%). (2) We identified WSIs
that have unusual segmentation statistics (too few/much segmented nuclei
etc.), then visually assess segmentation data in them, and marked slides
that have unacceptable segmentation (less than 80% of the slide both pre-
cision and recall are at least 75%). In these ways, we categorized WSIs
into groups with different segmentation quality levels.
Using the patch-level manual segmentation data in 14 different TCGA can-
cer types, we quantitatively evaluated segmentation data. We judged 10 of the
14 cancer types to have nuclear segmentation result quality worthy of publi-
cation and data release. We thus release the following validated data as our
contributions:
1. The automatic nucleus segmentation dataset contains 5,060 segmented
slides in 10 TCGA cancer types, summarized in Tab. 1. This represents
approximately 5 billion segmented objects. This large scale segmentation
data for TCGA slides is very important, since characteristics of nuclei are
essential for the diagnosis and study of cancer.
(a) We apply per-WSI level quality control and categorize WSIs into
groups with different segmentation quality levels. We identified 576
slides with suboptimal segmentation results. We filter out those WSIs
for further analysis (although we still release the data for complete-
ness).
(b) Based on our patch-level quantitative assessment, compared to man-
ual segmentation, in every cancer type, the average Dice coefficient of
nucleus segmentation data is at least 77%. Additionally, we are able
to count the number of nuclei per 64 × 64 µm2 patch to a Pearson
correlation of at least 90%.
#. slides #. slides
Abbre. Cancer type in total failed QC
BLCA Urothelial carcinoma of the bladder 380 14
BRCA Invasive carcinoma of the breast 1,096 88
CESC Cervical squamous cell carcinoma
and endocervical adenocarcinoma
249 54
GBM Glioblastoma Multiforme 772 40
LUAD Lung adenocarcinoma 540 59
LUSC Lung squamous cell carcinoma 431 35
PAAD Pancreatic adenocarcinoma 190 11
PRAD Prostate adenocarcinoma 387 19
SKCM Skin Cutaneous Melanoma 470 64
UCEC Endometrial Carcinoma of the Uter-
ine Corpua
545 192
Total 5,060 576
Table 1: The main contribution of our work: nucleus segmentation data in 10
cancer types. We also generated results in 4 additional cancer types (COAD:
colon adenocarcinoma, READ: rectal adenocarcinoma, STAD: stomach adeno-
carcinoma, UVM: Uveal Melanoma) that are not as good as the 10 cancer types.
To validate the segmentation data, we collected segmentation ground truth in
1,356 patches. This set of manually segmented data is another contribution of
our work.
2. Manual segmentation labels on 1,356 patches of 256 × 256 pixels (64
× 64 µm2) uniformly distributed in 14 cancer types. Two pathologists
collaborated with three graduate students employed results from Mask
R-CNN as a base to generate segmentation labels.
Examples of both datasets are shown in Fig. 1.
Methods
In this section, we first describe our nucleus segmentation method, then how we
validate the data product.
Robust nucleus segmentation
To generate accurate segmentation results in multiple cancer types, existing
state-of-the-art segmentation methods require extensive manually annotated
training data in each cancer type. This is not scalable in practice. To ad-
dress this problem, in addition to using manually annotated training data in
several cancer types, we synthesize heterogeneous training image patches, of
every tissue type available in The Cancer Genome Atlas (TCGA). This data
synthesize method is unsupervised, and is capable of generating half a million
H&E patch
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Figure 1: Samples of our data. (1). Automatic segmentation results on 5,060
WSIs (samples in top row), summarized in Tab. 1. (2). Manual segmentation
data on over 1,356 patches (samples in bottom rows). Coloring of nuclear masks
is for visualization only: it differentiates individual nuclei. We collect a large
number of patches with labels for validating the segmentation results.
training patches which normally requires thousands of human hours to manually
annotate. The workflow of our approach is shown in Fig. 2. We briefly describe
our approach in this section.
We first generate possibly realistic nuclear masks as random polygons. Then,
we construct an initial synthetic patch utilizing textures and colors from real
tissue (texture inpainting module in Fig. 2). We then refine the initial synthetic
patch, to make it more realistic. Along this process, we compute a sample weight
of this synthetic patch, indicating how realistic it is. Finally, we train a seg-
mentation network using the initially generated nuclear masks, refined synthetic
patch, and sample weight. In other words, we enumerate possible ground truth
structures first and then check if a resulting synthetic patch is realistic or not.
We decrease its impact in the training loss if it is not realistic. Similarly, if a
resulting patch is not only very realistic, but also rarely synthesized, then we
increase its impact in the training loss. Details are described in our technical
paper [19].
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Figure 2: Overview of our nucleus segmentation model training: we use a tex-
ture inpainting module to synthesize an initial synthetic pathology image patch
with its nuclear mask. We then refine the initial synthetic patch using a GAN
and compute its sample weight. We finally train a segmentation CNN on this
sampled instance. Details are in our technical paper [19] and source code repos-
itory.
In terms of the network architecture, the GAN’s refiner has 21 convolutional
layers and 2 pooling layers. The GAN’s refiner discriminator has 15 convolu-
tional layers and 3 pooling layers. As the segmentation CNNs, we use a U-net
with 8 blocks: 4 down-sampling blocks and 4 up-sampling blocks. Each block
has 3 to 6 convolutional layers and 1 pooling/deconv layer. We add a skip
connection between blocks of the same resolution. In total there are 43 convo-
lutional layers (including deconv). Each convolutional layer in the first and last
block have 16 filters. After each pooling layer, we double the number of filters.
We train the U-net on three real training datasets [23, 35, 25] and our large scale
synthetic dataset of 500,000 patches. The U-net has two output heads: one for
nuclear center detection and one for nuclear material segmentation. We then ap-
ply the watershed method [5, 3] on detected centers and segmentation results, to
output instance-level segmentation. During test time, we normalize stains [29] in
histopathology images before applying the U-net. For details of the implementa-
tion, refer to our github code: github.com/SBU-BMI/quip_cnn_segmentation.
Comparing to other state-of-the-art segmentation methods
Comparisons between our approach and other state-of-the-art level methods
are detailed in our technical paper [19]. As a summary, on the MICCAI17 [35],
MICCAI18 [25], and Kumar et al. [23] datasets, U-net trained with synthetic
and real training data achieved state-of-the-art level results, even though other
comparable baseline methods [6, 35, 20] use computationally more expensive
models.
WSI-level quality control
We visually assess segmentation quality per WSI, and categorize WSIs into
groups with different segmentation quality levels. In is very time consuming
for going through each WSI: visually checking segmentation results in one WSI
takes approximately 2.5 minutes; and thus 5,000 WSIs would require over 200
hours. Therefore, we sample segmentation data in each WSI-level in two ways:
Random segmentation region checking for quality control and rating
We checked segmentation quality in regions of all 5,060 WSIs at random loca-
tions. First, we randomly sample 15 patches per WSI and mix all patches from
all WSIs. This results in around 64,000 patches. Then, we go through those
patches and mark patches with reasonable segmentation results (both precision
and recall are at least 75%). Finally, we categorize WSIs into four groups, ac-
cording to the number of patches with bad segmentations, as shown in Tab.
2.
WSI-level quality control
To make sure that we identify most slides with unacceptable segmentation re-
sults, we select slides that have unusual segmentation statistics for visual assess-
Percentage of patches
WSI groups with bad segmentations #. slides
Best 0% 2,346
Good 0.01 - 6.67% 1,246
Adequate 6.68 - 13.3% 593
Problematic 13.4 - 20.0% 302
Unacceptable > 20.0% 573or failed WSI QC
Table 2: We categorize WSIs into groups with different segmentation quality lev-
els. Slides identified as having unacceptable segmentation results are excluded
from analysis in the rest of this work.
ment. We visually assess segmentation results in these slides and mark slides
with unacceptable results efficiently for quality control. We define “unusual
segmentation statistics” as the following:
1. Too much/few segmented nuclei.
2. Average size of segmented nuclei is too large/small.
3. Variation of the size of segmented nuclei is too large. Note that small
variance of size does not indicate low segmentation quality, based on our
observation.
In particular, we first compute the predicted nuclei count and average/variation
of nuclear size, for each segmented slide. Then, slides that have one or more
statistical values larger/smaller than 2% of the slides within the same cancer
type are selected for visual assessment using the caMicroscope web tool [32].
For a WSI, we rate the segmentation result in the slide as either acceptable or
unacceptable. Following the random segmentation region checking criterion, it is
acceptable if and only if in at least 80% of the slide both precision and recall are
at least 75%. Around 500 WSIs in total are selected for visual assessment. For
each cancer type, if a significant portion of the selected slides has unacceptable
results, we select another 2% (in total 4%) of slides in each statistic value for
visual assessment. In this way, 49 more slides were marked having unacceptable
segmentations. Slides with results marked as unacceptable are excluded from
analysis in the rest of this work.
We categorize WSIs into different levels of segmentation quality using ran-
dom segmentation region checking and WSI-level visual assessment results, as
summarized in Tab. 2.
Patch-level manual annotation data
To quantitatively evaluate and validate the automatic segmentation results in
each WSI group, we collect segmentation ground truth in 1,356 patches, uni-
formly distributed in 14 cancer types. Examples of manual segmentations are
shown in Fig. 1. Since this dataset is large scale and contain 14 cancer types, we
consider it as a contribution of our work as well. To collect this large scale ground
truth data, three graduate students, supervised by two pathologists, manually
corrected automatic segmentation results given by a Mask R-CNN (detailed
later in this section). Our manual segmentation is imperfect. However, its ac-
curacy is only rarely limited by atypical chromatin patterns or representation of
the entire nucleus in the plane of section, and rarely encompasses more than a
portion of the nuclear contour. The imperfection level of manual segmentation
results fell roughly within the range of variability that one would expect when
one compares data from different human annotators - the Dice scores of both
cases are within the range of 0.75 to 0.80.
Using this patch level segmentation ground truth, we evaluate the quality
of our automatic segmentation data in each cancer type. We found that our
results in 10 out of the 14 cancer types are relatively accurate. We release our
segmentation data in those 10 cancer types as our main contribution (Tab. 1).
Ground truth collection
We first extract patches of 256 pixels in 40X, randomly (unbiased) and uni-
formly distributed in 14 cancer types. We label extracted patches in two ways,
described below.
Fast manual segmentation by correcting Mask R-CNN’s segmentation
results. In order to label thousands of patches, we minimize human labor by
utilizing a Mask R-CNN - human annotators manually correct the Mask R-
CNN’s segmentation results in each patch, instead of labeling from scratch.
Mask R-CNN [17] is a state-of-the-art level instance level segmentation network
which although is not computationally efficient for segmenting over thousands of
slides, gives reasonable segmentation results. Another advantage of using Mask
R-CNN is that it has a different architecture compared to the U-net that we use
to generate segmentation results. This architectural different eliminates possible
biases for evaluation. In particular, we use the authors implementation [18] and
train a Mask R-CNN on the same real + synthetic dataset used for training
the U-net. We then apply the trained Mask R-CNN on 1,356 patches. Three
graduate students then correct the segmentation results by 1). Segmenting
unsegmented nuclei; 2). Removing false segmentations; 3). Modifying incorrect
segmentations. Manual segmentation results are reviewed by two pathologists
and patches significantly mislabeled are then relabeled. This process is a form
of crowdsourcing [2].
Manual segmentation from scratch. In order to evaluate the level of ap-
proximation in manual segmentation and the methodology of correcting Mask
R-CNN’s segmentation results, each of the three graduate students manually
label a common set of 27 patches from scratch (not by correcting the Mask
R-CNN’s results). As a result, each patch has three manual segmentations,
one from each student. Manual segmentation results are also reviewed by two
pathologists and patches significantly mislabeled are then relabeled. Note that
these patches were sampled from the same 1,356 patches described before.
Code availability
Source code is available at github.com/SBU-BMI/quip_cnn_segmentation. It
contains the following repositories:
training-data-synthesis Code for generating synthetic training data for nu-
cleus segmentation model training.
training-data-real-patch-extraction Code for converting the format of real
training data.
segmentation-of-nuclei Code for training a nucleus segmentation model on
patches generated by the above-mentioned repositories, and applying a trained
model on WSIs.
Detailed descriptions are in the README files in the Github repository.
We also provide a Dockerfile in Github, containing a trained model for easy
deployment.
Data Records
To access all data records described in this section, please visit
https://doi.org/10.7937/tcia.2019.4a4dkp9u or directly download data at
https://app.box.com/s/yd4pbndk2bxtnourzpbvopga8dczsnes.
Automatic nucleus segmentation data
The algorithm-generated segmentation results. For each cancer type, you can find a
cancertype_polygon folder, for example, BLCA_polygon. It contains polygon coordi-
nates for each segmented nucleus (csv files), for all WSIs of BLCA. These results are
obtained by thresholding the grayscale results in BLCA_prob folder and separating
touching or overlapping nuclei by combining the detection and segmentation results.
Each line in a csv file contains information of one nucleus. There are three columns in
a csv file:
• AreaInPixels Size of the nucleus in terms of the number of pixels.
• PhysicalSize The number of pixels projected to 40X.
• Polygon The contour of the nucleus (polygon vertices in [x0:y0:x1:y1:..]).
In addition to cancertype_polygon folders, there are cancertype_meta folders which
contain meta-data for each WSI. These folders are useless unless you use caMicroscope
[33] to visualize data.
Note: (1) In Box.com, the number of files under each folder shown in the “size”
column is approximate; (2) Whether a slide has Unacceptable segmentation result
or not is listed in the “list of histopathology slides” data described later. To further
recognize WSIs with Best/good/Adequate/Problematic segmentations, one can use
the “random segmentation region checking result” data described later.
List of histopathology slides
The list of 5,060 WSIs and summarized quality control results. This is a csv file with
the following columns:
• CancerType Cancer type of the WSI.
• WSI-ID The case ID of the WSI, in TCGA naming convention.
• QCResult The summarized quality control result (passed or failed).
We do not redistribute the actual WSIs. These gigapixel histopathology slides
can be downloaded from the publicly available The Cancer Genome Atlas (TCGA)
repository [34]. For example, to download Urothelial carcinoma of the bladder (BLCA)
slides, a user can:
1. Visit portal.gdc.cancer.gov/projects/TCGA-BLCA
2. Click on the “Files” link in the “Diagnostic Slide” row.
3. Click on the “Add All Files to Cart” bottom.
4. Go to your cart, and download all cart items.
WSI quality control result
The list of slides selected for quality control by visual assessment and the detailed
quality control result. This is a csv file with the following new columns (we do not list
columns that are already explained before):
• NumNucleiSample The number of segmented nuclei in this WSI.
• SizeOfNuclei-Average The average size of nuclei.
• SizeOfNuclei-Stddev The standard deviation of the size of nuclei.
• Note The reason of selecting this WSI for visual assessment.
• SegmentationUnacceptableOrNot 0: acceptable; ? or 1: unacceptable.
• VisualAssessmentComment Verbal comments on this WSI.
Random segmentation region checking result
The detailed result of random segmentation region checking for each WSI. This is a
csv file with the following new columns:
• NumOfUnacceptableSegRegions The number of unacceptable regions.
• NumOfSampledRegions The total number of visually assessed regions.
Manual segmentation data
The png images of manual segmentation data. Contains original H&E stained histopathol-
ogy image patches, and instance-level segmentation masks. Additional information is
in the readme.txt file of this data.
Technical Validation
We visually assess segmentation results in randomly sampled Whole Slide Images
(WSIs) and also quantitatively analysis segmentation quality using patch-level seg-
mentation labels.
WSI-level qualitative evaluation.
Qualitative evaluation on all segmented WSIs is impractical. We randomly select 328
WSIs uniformly from 10 cancer types - at least 32 WSIs per cancer type to evaluate
qualitatively. We use the same evaluation criterion used in the quality control process.
Segmentation results in each slide is categorized as either acceptable or unacceptable.
It is acceptable if and only if in at least 80% of the slide both precision and recall are
at least 75%.
Out of the 328 randomly selected WSIs, 15 were marked as having unacceptable
results. This concludes that our segmentation results on vast majority of WSIs are ac-
ceptable. We show examples of segmentation results in relatively large histopathology
image tiles in Fig. 1.
Patch-level quantitative evaluation
We use manually annotated patches for quantitative evaluation. Note that we only
use 971 patches in 10 cancer types, out of the 1,356 manually segmented patches in
14 cancer types. We only use manual segmentation in the center 226 × 226 pixels in
each patch (as opposed to the entire 256 × 256 pixel patch), since segmentation close
to the boundary is ambiguous due to incomplete data.
Evaluation metric
We use the Dice coefficient for measuring the quality of class-level (nuclear material or
not) segmentation. Dice is ill-defined in patches that do not have any ground truth or
predicted segmentation. To address this problem, the final Dice score is the average of
per-patch Dice scores, weighted by the number of nuclei (ground truth nuclei count +
predicted nuclei count) in each patch. To jointly measure the quality of segmentation
and the quality of separating individual nuclei, we use the Instance-Dice score which
is also used in the MICCAI nucleus segmentation challenge [35, 25]. In addition, we
compute the Pearson correlation and Mean Absolute Error Ratio (MAE%) between
the number of nuclei segmented by U-net (defined as p), against the number of nuclei
segmented by human annotators (defined as t). The MAE% is computed below:
MAE% =
|p− t|
t
, (1)
When we compute MAE% on a set of patches, we first compute the average of |p− t|
and t across all patches, then compute their ratio.
Generated segmentation results vs. corrected Mask R-CNN’s results
We compare the automatic segmentation results with the manual segmentations ob-
tained from correcting Mask R-CNN’s results. The overall accuracy of generated
segmentation results is shown in Tab. 3. A scatter chart (Fig. 4) shows the accuracy
of the predicted nuclei count. We also show per-cancer type evaluation results in Tab.
4.
Evaluating level of approximation in manual segmentation
We evaluate the level of approximation in manual segmentation by comparing each
annotator’s segmentation result with each other. We apply the evaluation metrics
Dice: 78%, MAE%: 24%
Dice: 64%, MAE%: 45% Dice: 54%, MAE%: 35%
Dice: 84%, MAE%: 23%
Dice: 84%, MAE%: 5%
Dice: 41%, MAE%: 56%Dice: 70%, MAE%: 59%
Dice: 81%, MAE%: 4%
H&E patch Our automatic 
segmentation
Manual segmentation 
(corrected Mask R-CNN)
H&E patch Our automatic 
segmentation
Manual segmentation 
(corrected Mask R-CNN)
Figure 3: Examples of automatic segmentation vs. manual segmentation. First
two rows: failure cases. Last two rows: randomly selected samples.
#. patch Instance- Nuclei count
WSI groups labels Dice Dice Correlat. MAE%
Best 446 0.797 0.687 0.947 15.2%
Good 242 0.789 0.660 0.930 16.1%
Adequate 128 0.774 0.636 0.915 17.6%
Problematic 52 0.788 0.625 0.879 20.5%
Unacceptable 103 0.690 0.545 0.718 33.8%
Excluding unacceptable 868 0.790 0.667 0.932 16.2%
Table 3: Quantitative assessment of the quality of nucleus segmentation, across
10 cancer types. The definition of WSI groups are given in Tab. 2. We exclude
unacceptable segmentation results from analysis work in the rest of this paper.
Cancer #. patch Instance- Nuclei count
Type labels Dice Dice Correlat. MAE%
BLCA 95 0.779 0.668 0.941 20.5%
BRCA 89 0.798 0.649 0.922 19.6%
CESC 79 0.818 0.677 0.947 13.4%
GBM 86 0.809 0.723 0.938 14.4%
LUAD 88 0.772 0.641 0.896 17.4%
LUSC 97 0.789 0.665 0.924 16.1%
PAAD 91 0.785 0.679 0.933 15.8%
PRAD 96 0.799 0.670 0.940 14.7%
SKCM 86 0.774 0.675 0.933 17.1%
UCEC 61 0.778 0.629 0.900 14.6%
Table 4: Quantitative assessment of the quality of nucleus segmentation, in each
of the 10 cancer types. The p-value of Pearson correlation for every cancer type
is smaller than < 7.0× 10−23.
Instance- Nuclei count
Inter-annotator Dice Dice Correlat. MAE%
Annotator A vs. B 0.760 0.600 0.959 10.8%
Annotator B vs. C 0.752 0.622 0.959 15.5%
Annotator C vs. A 0.774 0.697 0.954 12.2%
Table 5: Agreements between annotations from different human annotators.
This is the performance upper bond of any automatic segmentation method.
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Figure 4: Top: Dice and MAE% results of all patches. Bottom: Predicted
nuclei count (derived from automatic segmentation) vs. Ground truth nuclei
count (derived from manual segmentation). Pearson correlation = 0.932, p-
value < 1.0× 10−308.
Instance- Nuclei count
Annotator Dice Dice Correlat. MAE%
Annotator A 0.803 0.664 0.962 12.4%
Annotator B 0.793 0.631 0.984 11.2%
Annotator C 0.780 0.683 0.973 9.5%
Table 6: Comparing labeling from scratch vs. correcting Mask R-CNN’s results.
between each pair of students, shown in Tab. 5. One observation that in many cases,
it is uncertain whether an object in histopathology images is a nucleus or not. This
also contributes to the segmentation disagreement between human annotators.
Labeling from scratch vs. correcting Mask R-CNN’s results
Finally, we evaluate how the labeling from scratch vs. correcting Mask R-CNN’s
results differ. For the 27 patches that were labeled from scratch, there are also the
Mask R-CNN’s corrected results. Evaluation results are in Tab. 6.
Usage Notes
We use CC0 (no copyright reserved) for our data.
Due to implementation and memory limitations, automatic nucleus segmentation
results were generated and stored in 4,000 by 4,000 pixel tiles, as supposed to the entire
WSI. Thus, nuclei across multiple tiles are split into different tiles. Additionally, we do
not segment nuclei in tiles whose width or height is less than 2,000 pixels (this might
happen on the edge of a WSI). All validation results include these by-design errors.
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